Does it help with egg production?

Yes, it can improve laying rate by 2% and reduce egg broken rate by 30% to 50%.

What is the packaging size?

1kg per sachet, with 20 sachets per carton.

Do you offer OEM and ODM services?

Yes, we offer both OEM and ODM services.

Veterinary Feed Additives Broiler Premix Vitamin Mineral Supplement

Name: Veterinary Feed Additives Broiler Premix Vitamin Mineral Supplement
Brand: Henan Muxiang Biological Co., Ltd.
SKU: 1950304482

Henan, ChinaHenan Muxiang Biological Co., Ltd.

US$0.99-6.99

1,000 kg

Product profile

Customization

Available

Varieties

General Disease Prevention Medicine

Component

Chemical Synthetic Drugs

Model NO.

100g/bag; 500g/bag; 1kg/bag

Type

The First Class

Pharmacodynamic Influential Factors

Combined Medication

Storage Method

Light Proof

Transport Package

Carton; Bucket

Specification

500g/bag, 1kg/bag

Trademark

MOOSUN

Origin

China

HS Code

3004909090

Production Capacity

50000pieces /Month

Key features

Comprehensive Nutritional Formula: Contains 13 kinds of vitamins and 5 kinds of organic trace elements for balanced nutrition.

Customizable Formula: Formula can be customized to meet specific requirements.

Stress Resistance Support: Effectively combats heat, illness, immune, and weather changing stress.

Disease Prevention: Prevents vitamin deficiency, fatty liver, weak foot disease, and sudden death syndrome.

Enhanced Production Performance: High biological value strongly improves production performance and recovery.

Improved Egg Quality: Increases laying rate by 2% and reduces egg broken rate by 30% to 50%.

Long Shelf Life: Guaranteed expiry date of 2 years when stored properly.

OEM and ODM Services: Manufacturer offers both OEM and ODM services with 20 R&D engineers.

Company profile

Henan Muxiang Biological Co., Ltd.

Henan, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2016-02-01 CertifiedNearest Port: Shanghai Port, Qingdao PortAverage Response Time: ≤11.61h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryHenan Muxiang Biological Co., Ltd. is a China-based limited-company factory established in 2004, with 360 employees and operations in veterinary pharmaceuticals and animal-health products. The supplier reports seven pharmaceutical production lines, eight vaccine production lines, first-class production and inspection equipment, GMP management, ISO9001:2015 certification, and ISO/CNAS laboratory certification. Its R&D resources include more than 40 core personnel, over 30 of whom hold doctoral or master's degrees, while 21–30 quality-control staff are reported. The company exports to multiple global regions, has self-operated import and export rights, and states a one-month order-fulfillment period in both peak and off-peak seasons. Evidence supports capabilities in certification, innovation, production, and international operations. However, the provided information does not sufficiently establish after-sales service performance, financial credibility, customization execution, or specific customer cases.

Supplier typeThe supplier is identified as a limited company and a factory in the manufacturing industry, with its operating location in Henan, China. This indicates a direct manufacturing entity rather than only a trading or intermediary business.

CertificationsThe supplier reports a systematic GMP management system, ISO/CNAS laboratory international certification, and an ISO9001:2015 certificate. These stated certifications and quality systems provide explicit evidence of formal quality-management capability.

R&D capabilityThe supplier reports more than 40 core R&D personnel, including over 30 doctors or master's degree graduates, 20 years of preparation-technology experience among R&D engineers, and advanced R&D platforms such as a National Enterprise Technology Center, National Postdoctoral Research Station, and Academician Workstation. It also reports improving herbal active-ingredient extraction by more than 30% versus a traditional process, supporting a strong stated innovation profile.

Production capacityThe supplier reports seven pharmaceutical production lines and eight vaccine production lines, first-class production and inspection equipment, six production lines in a separate operational data field, and one-month order fulfillment in both peak and off-peak seasons. Although the line-count figures are not fully consistent across the slices, the evidence clearly supports substantial pharmaceutical and vaccine manufacturing capability.